INOVIS  EVENTS

PharmaCI EUR Conference & Exhibition

• Rome ITALY
• 30-31 MAR 2023
• conference web site>

join INOVIS at more events +

MASTERCLASS — 2:05 to 4:05 pm
Developing a Competitive Activity Framework to enhance organizational competitiveness

presented by

Dr. Harshal Kubavat
Head of Strategic Consulting, Global Pharmaceuticals & Life Sciences Group, INOVIS
   

This workshop session (with breakouts), will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS' in-house proprietary methodologies.

Key to this session will be addressing business needs across the lifecycle, whereby participants will:

1. Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
2. Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
3. Receive hands-on opportunities to apply learnings to a pharma case study in a learning environment

Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you're a seasoned CI professional veteran, or newer to the field.

DAY ONE, KEYNOTE — 11:35 to 12:05pm
Generics & Biosimilars - Important Learnings from Real World Case Studies

presented by

Dr. Baljit Singh
Managing Director & Partner, INOVIS
(formerly Director Insights, Novartis Pharma AG)
   

This session highlights innovative approaches leveraged by generic and biosimilars to speed up market entry. Specifically this presentation will enable you to:

1. Advance your understanding of core regulatory routes, timelines and strategies
2. Understand core Gx/biosimilar product development and entry strategies
3. Learn from and set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program

The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual regulatory approaches